An expert panel from India’s top drug regulator on Saturday recommended restricted emergency approval for Covaxin, Bharat Biotech’s Covid-19 candidate vaccine currently being tested in the country. The panel of experts now recommended a restricted authorization for two candidate vaccines in as many days; on Friday, it recommended similar approval …
Read More »Expert Panel Recommends Granting Approval for Emergency Restricted Use of Covaxin from Bharat Biotech
An expert panel from India’s central drug authority on Saturday recommended granting permission for the restricted use of the indigenous COVID-19 vaccine developed by Bharat Biotech Covaxin in an emergency situation, especially in the context of infection by mutant strains, authorities said. The recommendation for the Bharat Biotech vaccine came …
Read More »